Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.810
-0.010 (-0.55%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Employees
Serina Therapeutics had 16 employees as of December 31, 2025. The number of employees increased by 3 or 23.08% compared to the previous year.
Employees
16
Change (1Y)
3
Growth (1Y)
23.08%
Revenue / Employee
$8,125
Profits / Employee
-$1,347,375
Market Cap
27.15M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16 | 3 | 23.08% |
| Dec 31, 2024 | 13 | 2 | 18.18% |
| Dec 31, 2023 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Evaxion | 46 |
| Vistagen Therapeutics | 41 |
| Kyntra Bio | 34 |
| Plus Therapeutics | 28 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Barinthus Biotherapeutics | 14 |
SER News
- 10 days ago - Serina Therapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Serina Therapeutics files to sell 16.45M shares of common stock for holders - TheFly
- 5 weeks ago - Serina Therapeutics Registration statement: Registration filing - Filings
- 6 weeks ago - Serina Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Serina Therapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - Serina Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Serina Therapeutics Proxy statement: Proxy filing - Filings